Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06822439Recruiting

Remote Fetal Monitoring in High Risk Pregnancies

Role: collaborator

NCT06497205Recruiting

AMBulatory Fetal ECG Monitoring in Low and High-Risk Pregnancies

Role: lead

NCT06490471Not Yet Recruiting

Femom System Compared to the Standard of Care CTG

Role: lead

NCT04941534Completed

This Clinical Study Evaluates the Performance and Safety of Biorithm Research Kit Versus CTG in Prenatal Monitoring of Pregnant Participants.

Role: lead

All 4 trials loaded